What is Molbio Diagnostics IPO price?

₹807 per share. Confirm in the RHP before applying.

What is Molbio Diagnostics IPO GMP?

₹143 (+17.7%). Unofficial — changes daily.

When is Molbio Diagnostics allotment?

Expected around 13 Aug 2026. Check the registrar link on this page.

Back to IPO List

Molbio Diagnostics IPO

MainboardListed

Allotment Status

Registrar: KFintech

Check Allotment Status

Listing performance

+21.44% on listing day

Issue price

₹807

Listing price

₹980.021

Last GMP (₹)

₹143

GMP estimate

+17.72%

Actual listing gain

+21.44%

Return per lot

+₹3,114.374

GMP vs listing performance

GMP estimate+17.72%

Actual listing gain+21.44%

GMP pointed to +17.72% but the stock listed at +21.44% — 3.7% higher than estimated.

Listing gain calculator

Estimate profit or loss based on actual listing performance

Lots

Investment: ₹14,526
Listing value: ₹17,640
Listing gain: +21.44%
Profit (1 lot): +₹3,114

Based on issue price ₹807 × 18 shares per lot. Listing price ₹980. Excludes taxes, DP charges, and selling costs.

Listing results from exchange debut data where recorded. See GMP accuracy report · How we track this

Pricing Information

Price Range₹807

GMP₹143

Listing Gain17.72%

Lot Size18

Important Dates

Bidding Start10 Aug 2026

Bidding End12 Aug 2026

Allotment Date13 Aug 2026

Listing Date17 Aug 2026

Subscription

Overall Subscription70.27x

Additional Information

Issue Size₹939.70 Cr

Molbio Diagnostics IPO — Quick Analysis

Listing result:+21.4% listing gain

GMP signal:Moderate premium

Subscription:70.27x — well oversubscribed

Molbio Diagnostics IPO listed on 17 Aug 2026 at an issue price of ₹807, gained 21.4% on listing day. It delivered strong listing returns for allottees. The issue was subscribed 70.27x overall.

Overview

Molbio Diagnostics is a recently listed Mainboard IPO in India, raising ₹939.70 Cr, with shares offered around ₹807. The stock has listed with a +21.4% debut move versus the issue price. For business fundamentals, revenue trends, and use of proceeds, read the RHP on SEBI or NSE/BSE — we summarise market metrics, not audited financials.

GMP and subscription figures are unofficial market data, refreshed twice daily for active IPOs. Last updated 12 Aug 2026, 05:24 pm IST. How we source data · Disclaimer

Strengths

Subscribed 70.27x — strong demand.
Positive GMP of ₹143 (+17.7%).
Mainboard listing — deeper liquidity on NSE/BSE.

Risks

Listing price can fall below issue price despite positive GMP.
GMP is unofficial — not a confirmed listing outcome.

FAQ

Molbio Diagnostics IPO questions

What is Molbio Diagnostics IPO price?: ₹807 per share. Confirm in the RHP before applying.
What is Molbio Diagnostics IPO GMP?: ₹143 (+17.7%). Unofficial — changes daily.
When is Molbio Diagnostics allotment?: Expected around 13 Aug 2026. Check the registrar link on this page.

Livemint17 Aug 2026

Molbio Diagnostics IPO listing: Shares debut at a 21% premium, defying weak stock market sentiment

Molbio Diagnostics' IPO listed at ₹980 on the BSE and NSE, a 21.44% premium to the issue price of ₹807. The stock's grey market premium was ₹120 on the morning of listing. The strong listing defied the current weak stock market sentiment.

Read full story

Economic Times17 Aug 2026

Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSE

Molbio Diagnostics shares listed at a 21.44% premium over its IPO price of Rs 807 on BSE and NSE. The company's Rs 939.70 crore IPO was subscribed 70.26 times, primarily driven by QIBs. The listing price reflects a strong market debut for the diagnostics firm.

Read full story

Economic Times13 Aug 2026

Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check status

Molbio Diagnostics' IPO allotment is expected to take place today, after the issue was subscribed 70.26 times. The company's grey market premium is around 20%. The IPO proceeds will be used to fund research and development infrastructure, manufacturing expansion, and corporate purposes.

Read full story